HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Esophageal Varices in Adolescent and Young Adult Males with Acute Lymphocytic Leukemia.

Abstract
Hepatic late effects are not commonly reported in survivors of childhood leukemia. Four young male patients with acute lymphoblastic leukemia (ALL) were diagnosed with bleeding esophageal varices (EVs) during or shortly after completion of maintenance chemotherapy. EVs were identified from 0 to 60 months after completion of leukemia therapy. All four patients were men between 20 to 24 years old. Hematemesis was the most common presenting symptom. Associated features included splenomegaly, cytopenias, azole therapy, alcohol use, and hepatic iron overload. EVs may be an under-recognized complication of ALL therapy, with adolescent and young adult males at highest risk.
AuthorsLauren Nicholls, Jana Montez, Luz Pelayo-Katsanis, Emmanuel Katsanis
JournalJournal of adolescent and young adult oncology (J Adolesc Young Adult Oncol) Vol. 8 Issue 2 Pg. 217-220 (04 2019) ISSN: 2156-535X [Electronic] United States
PMID30335538 (Publication Type: Case Reports, Journal Article)
Topics
  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects)
  • Esophageal and Gastric Varices (chemically induced, pathology)
  • Humans
  • Maintenance Chemotherapy (adverse effects)
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (drug therapy, pathology)
  • Prognosis
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: